Learn more about our comprehensive legal services.
Advising our clients on different opportunities and challenges of the industry.
Deacons’ Life Sciences and Healthcare team provides comprehensive legal services to businesses in the biotechnology, pharmaceuticals, medical devices, healthcare and consumer health sectors. Our lawyers advise clients on all areas of transactional, regulatory, intellectual property, litigation, and other related issues throughout the product life cycle.
The life sciences industry is based on innovation and each new development and discovery brings constantly evolving risks. Life sciences and healthcare companies face an increasingly complex regulatory environment, funding challenges and the difficulties of intellectual property management, where the most valuable assets may also be the most vulnerable. With data analytics and the personalization of medicine playing a critical new role in the healthcare sector, the impact of data protection on life sciences can also be far-reaching.
We recognise that legal and business strategy is as important as R&D. Our team members advise on the protection and commercialisation of research and development in new products in areas ranging from medical devices, biological pharmaceuticals, “personalised” molecular medicine including cellular and genetic therapies, to enhanced cancer screening, protein therapies and new medicine delivery mechanisms. We also have a long history of involvement in cutting edge litigation, having successfully represented the plaintiffs in many of Hong Kong’s most significant intellectual property litigation cases, including patent infringement proceedings relating to genetic sequencing and pre-natal genetic testing technologies. We are also experienced in handling some of the most complex litigation matters in Mainland China, such as advising a leading agribusiness on enforcement and litigation matters arising from plant variety rights.
The advantage of being a full-service law firm is that we can bring our capabilities in a broad range of areas such as capital markets, intellectual property, litigation, corporate and human resources into play.
Our capital markets team advises on fund raising from inception through pre-IPO, IPO and post-IPO secondary offering. Deacons has recently advised biotech companies on preparation of Chapter 18A listings. We have also advised numerous healthcare and pharmaceutical companies on successful listings on the Hong Kong Stock Exchange.
Our commercial team has very broad experience in the sector ranging from M&A and joint ventures to advisory work on clinical trial projects, medical devices, product recall, pharmaceutical regulation and licensing, product labelling and general marketing issues.
Scope of Services
Our services include:
Sign up for Life Sciences and Healthcare Notifications
Sign up for our regular updates covering Life Sciences and Healthcare regulations and case law.